Ziopharm

Ziopharm's new CEO fires half of his workforce in first month

Less than 30 days into his post as CEO, Kevin Boyle laid off more than 50% of his staff as the company looks to move into a phase 1/2 trial next year.

Kyle LaHucik Sep 28, 2021 10:05am

Ziopharm cuts Precigen ties, narrowing its R&D focus

Oct 10, 2018 11:05am